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Background: While body mass index percentiles (BMI%) are commonly used to assess childhood cardiovascular
risk, waist circumference percentiles (WC%) are not commonly used nor universally accepted. We tested whether
BMI% or WC% should be used to identify risk factor patterns in children at high-risk for developing cardiovascular
disease (CVD). A total of 107 children (8–19 years) with cardiovascular risk factors or a family history of CVD were
studied. Tobacco exposure, screen-time, blood pressure and anthropometric measures were made, as well as serum
risk markers. Principal component analysis (PCA) was used to identify patterns explaining risk factor variance.
Multiple linear regression was used to test for associations between risk factor patterns, BMI% and WC%.
Results: An adverse lipid pattern (low HDL, high triglycerides and LDL), a pro-inflammatory pattern (high ICAM and
TNFαR2), a high blood pressure pattern (high SBP and DBP) and a high Lp(a) pattern were identified. Higher BMI%
and WC% were associated with significantly higher levels of the lipid pattern (p < 0.05). BMI% explained 20% of
variance in this pattern, whereas WC% explained 22%. When both BMI% and WC% were used together, neither
BMI% nor WC% were significantly associated with the lipid pattern. However, BMI% was significantly associated
with lower levels of the pro-inflammatory pattern, and WC% was associated higher levels of the pro-inflammatory
pattern - together explaining 12% of variance.
Conclusion: In children at high-risk for CVD, BMI% or WC% explained similar variance in an adverse lipid pattern;
however, the combination of BMI% and WC% explained greater variance in a pro-inflammatory pattern than either
alone. Both WC% and BMI% should both be used in anthropometric assessments of high-risk children.
Keywords: Waist circumference, Abdominal obesity, Biomarkers, Epidemiology, Factor analysisBackground
Adiposity (overweight and obesity) is a powerful risk
factor for cardiovascular disease (CVD) [1], and is recog-
nized in recent obesity screening and treatment guide-
lines for both adults [2] and children [3,4] Adipocytes
secrete fatty acids, express renin-angiotensin system
components (e.g. angiotensin converting enzymes), and
release inflammatory factors which advance atherosclerosis
by respectively promoting hyperlipidemia and insulin resist-
ance, high blood pressure, and vascular inflammation [5].
In particular, visceral adipocytes are extremely metabolically* Correspondence: lawrence.dekoning@cls.ab.ca
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unless otherwise stated.active, and are potent sources of these compounds - espe-
cially inflammatory factors, which are recognized as both
risk factors and common pathologic features of CVD [6].
Measures of abdominal adiposity such as waist circum-
ference (WC) indirectly assess visceral adipose tissue, and
are associated with an increased risk of cardiovascular
events [7]. Despite their sometimes high correlation with
BMI, using them with along with BMI often improves the
predictive power of models [8,9]. The importance of
abdominal obesity assessment was recognized in 2008 by
the College of Family Physicians of Canada, which en-
dorsed the routine measurement of WC in adults [10]. In
children, WC is assessed as a percentile for age and sex;
however the role of WC percentiles in pediatric cardio-
metabolic risk assessment is unknown.tral. This is an Open Access article distributed under the terms of the Creative
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sectional associations of BMI and WC percentiles with
patterns of cardiovascular risk markers – including in-
flammatory factors - in a population of children referred
to a preventative cardiology clinic.
Methods
This study was approved by the institutional review
board of Boston Children’s Hospital, and all research
conducted was consistent with declaration of Helsinki.
Informed consent was obtained from parents or guardians
of all participants.
A total of 150 participants aged 8–18 years of age were
initially recruited from the Preventive Cardiology Clinic
of Boston Children’s Hospital, Boston, Massachusetts.
Medical and family history was collected by review of
the clinic chart, electronic medical record and interview
of a parent and patient. Family history of premature car-
diovascular disease was defined as heart attack, stroke,
angioplasty, stenting, coronary artery bypass grafting
(CABG), peripheral arterial disease (PAD), sudden death
occurring < 55 years in male and <65 years in female
relatives (parents, aunts, uncles, grandparents), in a man-
ner consistent with the National Cholesterol Education
Program (NCEP) [11] and the American Academy of
Pediatrics (AAP) [3,12]. All demographic information was
collected by parental self-report, including exposure to
tobacco smoke in the home, hours per day of television
watching and computer gaming (screen time), racial back-
ground (Black, White, Other [includes Asian, Hispanic,
Pacific Islander, Native American], and family history of
cardiovascular disease (parent, grandparent, aunt, uncle or
sibling).
Anthropometric measures
We used the body mass index (BMI) as a measure of
overall adiposity, and WC as a measure of abdominal
adiposity. Height and weight were measured using a
standing scale and stadiometer, and WC was measured
at the level of the superior iliac crest using a tape meas-
ure. The average of two WC measures was recorded.
BMI was calculated as weight in kg divided by height in
meters squared. BMI percentile was determined using
Centers for Disease Control (CDC) growth charts [13].
Overall obesity was defined as a BMI ≥ 95% percentile of
BMI for age and sex [14,15], and abdominal obesity was
defined as a WC ≥ 90th percentile for age and sex [16].
Systolic (SBP) and diastolic (DBP) blood pressure were
measured initially using an oscillometric cuff (Dinamap).
The average of 2–3 recordings of SBP and DBP were ob-
tained using appropriately sized cuffs using standard
techniques, and converted into percentiles [17]. Elevated
blood pressures (SBP > 140 mmHG, DBP > 90 mmHg)
were rechecked by auscultation by experienced clinicians[17]. High blood pressure was defined as a SBP or DBP ≥
95th percentile [17].
Laboratory measurement of risk markers
A serum sample was obtained from 107 participants
after a 12-hour fast, and the following tests were per-
formed: total cholesterol (TC), high density lipoprotein
cholesterol (HDL), triglycerides (TG), low-density lipopro-
tein cholesterol (LDL; calculated), soluble tumor necrosis
factor-alpha receptor 2 (TNF-αR2), P-selectin, intracellu-
lar adhesion molecule-1 (ICAM-1), and C-reactive protein
using a high sensitivity assay (hs-CRP). Soluble tumor
necrosis factor-alpha receptor 2 (TNF-αR2) is the more
stable receptor of TNF-α, − which is an early inflam-
matory stimulator of endothelium [18]. P-selectin and
ICAM-1 are both endothelial cell adhesion molecules for
monocytes and lymphocytes, and C-reactive protein is a
pentameric inflammatory marker that binds to bacterial
cell wall components [18].
Lipids were measured enzymatically with a Hitachi 911
analyzer using reagents and calibrators from Roche Diag-
nostics (Indianapolis, IN, USA). The Friedewald equation
was used to calculate LDL (TC – (TG/5 +HDL)) if triglyc-
erides were less than 400 mg/dL. A direct method was
used to measure LDL if triglycerides were > 400 mg/dL.
Very low-density lipoprotein (VLDL) was estimated as the
difference between TC and all other major lipoprotein frac-
tions (TC – (LDL +HDL)). National Heart Lung and Blood
Institute guidelines (NHLBI) were used to identify individ-
uals with high TC (≥200 mg/dL), high LDL cholesterol
(≥130 mg/dL) and low HDL cholesterol (<40 mg/dL) [19].
Lipoprotein(a) was measured with a turbidimetric
assay on the Hitachi 911 analyzer (Roche Diagnostics)
using reagents and calibrators from Denka Seiken (Nii-
gata, Japan). This is the only commercial assay not af-
fected by Kringle type 2 repeats [20]. The concentration
of C-reactive protein was determined using a high-
sensitivity (hs-CRP) immunoturbidimetric assay on the
Hitachi 911 analyzer (Roche Diagnostics), using reagents
and calibrators from Denka Seiken (Niigata, Japan). Sol-
uble tumor necrosis factor-alpha receptor 2 (TNF-αR2),
P-selectin, and intracellular adhesion molecule-1 (ICAM-1)
were measured using enzyme-linked immunosorbent assays
(ELISAs) from R & D Systems (Minneapolis, MN, USA).
All samples were assayed in duplicate. Samples with
disparate results (coefficient of variance [CV] for dupli-
cates > 10%) were re-assayed a third time. Day to day and
within run coefficients of variance (CV) for all assays
were <10%. The CVs for lipid tests were less than 2%.
Statistical analysis
Continuous sex and race-specific (Black, White, Other)
WC percentiles were interpolated from National Health
and Nutrition Examination Survey (NHANES; 1999–2008)
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package). To reduce bias associated with extrapolating
beyond the data, participant WC percentile above the 90th
percentile or below the 10th percentile were rounded to
95% and 5%, respectively. The mean and standard devi-
ation (SD) were calculated for all continuous variables.
Risk markers were log-transformed prior to statistical
tests and regression modeling to normalize skewed
distributions. Unpaired Student’s T tests and chi squared
tests were used to compare the means and propor-
tions of each variable according to overall and abdominal
obesity.
Principal component analysis (PCA) with varimax
rotation was used to identify the first four independent
patterns of risk markers (Proc Factor) that would explain
the majority of variance in risk marker data. A continu-
ous score was derived for each participant representing
how closely their risk markers levels conformed to each
pattern (Proc Score). Scores were then divided into
quintiles for ease of interpretation.
Linear regression was used to assess the relationships
between BMI percentile, WC percentile and quintiles of
risk marker scores (Proc Reg). Partial correlation coeffi-
cients were calculated to determine the independent
explanatory power of BMI and WC percentile on each
score. All regression models were adjusted for exposure
to cigarette smoke (Yes vs No), family history of cardio-
vascular disease (Yes vs No), screen time (hours), and
race (Black, White vs Other). Analyses were performed
in SAS ver 9.3 (Cary, NC, USA) and R version 2.15.1.
Results
One hundred and seven participants, primarily non-
Hispanic whites (82%), with an average age of 13.3 years
were enrolled in the study (Table 1). Participants were at
generally high risk due to high TC (58%) or hypertension
(14%), as one would expect among participants recruited
from a Preventive Cardiology clinic, and spent on aver-
age 2.7 hours per day watching television and playing
computer games. Over half the participants had a family
history of coronary heart disease (51%). All participants
had hs-CRP concentrations below 1 mg/L – which
denotes low cardiovascular risk in adults [22].
Forty three percent of participants were classified as
obese, whereas 33% were abdominally obese. The correl-
ation of BMI percentile and WC percentile was 0.88.
Compared to participants who were not obese, those
who were obese were significantly less likely to be white
and more likely to be exposed to tobacco smoke, have
higher WC percentiles, triglycerides, VLDL cholesterol,
hs-CRP, and ICAM-1 levels and lower LDL and HDL
cholesterol. Compared to participants who were not ab-
dominally obese, those who were abdominally obese were
significantly younger, more likely to be from another racialgroup besides Black and White, had significantly higher
BMI, triglycerides, hs-CRP, ICAM-1, TNF-αR2 but lower
HDL cholesterol (Table 1).
Extraction of the first four factors using PCA identified
a common clustering of risk markers suggestive of (1) an
adverse lipid pattern (25% of variance explained) domi-
nated by strong positive correlations (0.93) with triglyc-
erides and VLDL, but a negative correlation with HDL
(−0.74), (2) a pro-inflammatory pattern (14% of variance
explained) having high correlations (>0.84) with ICAM-1
and TNF-αR2, (3) a high blood pressure pattern (12% of
variance explained) having positive (>0.66) correlations
with SBP and DBP and (4) an elevated Lp (a) pattern (10%
of variance explained), having a high positive correlation
with Lp(a) (0.75) (Table 2).
Both BMI and WC percentiles were significantly asso-
ciated with higher scores for the lipid pattern (Table 3).
That is, a greater degree of overall or abdominal adipos-
ity was associated with higher scores representing a con-
stellation of lipid abnormalities including higher TG and
VLDL, but lower HDL. Each metric explained between
20 and 22% of variance in this pattern. Neither metric
was significantly associated with any of the other patterns.
However when BMI and WC percentiles were included in
the same model, both were significantly associated with
the inflammatory pattern – but in opposite directions. In
this analysis, an increase in BMI percentile was associ-
ated with a decrease in the inflammatory pattern score,
whereas an increase in WC percentile was associated
with an increase in the inflammatory factor score.
Discussion
In a pediatric population at high-risk for developing
cardiovascular disease, both overall and abdominal
adiposity as measured by BMI and WC percentiles were
similarly associated with an adverse pattern of lipid
markers including high TG, high VLDL cholesterol, and
low HDL cholesterol. However when considered together,
increasing WC percentile was associated with higher
levels of a pro-inflammatory pattern whereas increasing
BMI percentile was associated with lower levels – together
explaining greater variance in this pattern than either
alone.
Anthropometric assessment of cardiovascular disease
risk is now routine clinical practice, mainly because adi-
posity is a major risk factor for conditions that lead to
cardiovascular disease – including abnormal lipids, high
blood pressure, and type 2 diabetes [5]. Increasing atten-
tion is now being paid to abdominal adiposity, character-
ized by an increased WC or waist to hip ratio, because it
provides information about risk for cardiovascular dis-
ease above and beyond that provided by BMI [23]. This
is particularly the case when systemic inflammation is
of interest, because abdominal adiposity is more closely









% (n) 100 (107) 57 (61) 43 (46) 67 (72) 33 (35)
Age, y (sd) 13.3 (2.7) 13.5 (2.9) 13.0 (2.5) 13.7 (3.0) 12.4 (2.2)*
Race/ethnicity
% White (n) 82 (88) 90 (55) 72 (33)* 85 (61) 77 (27)
% Black (n) 5.6 (6) 3.3 (2) 8.7 (4) 5.6 (4) 5.7 (2)
% Other racial group (n) 12.1 (13) 6.6 (4) 19.6 (9)* 9.7 (7) 17.1 (6)*
% Exposed to tobacco smoke (n) 19 (20) 8 (5) 33 (15)* 13 (9) 31 (11)*
% Family history of CHD (n) 51 (55) 51 (31) 52 (24) 53 (38) 49 (17)
Screen time, hours^(sd) 2.7 (2.3) 2.4 (1.7) 3.1 (2.9) 2.8 (2.5) 2.5 (1.9)
BMI percentile (n) 80 (23) 68 (24) 97 (1)* 72 (24) 97 (2)*
BMI, kg/m2 (sd) 25 (6) 21 (3) 30 (5)* 22 (4) 30 (6)*
WC percentile (n) 87 (16) 54 (23) 91 (6)* 58 (23) 95 (0)*
WC, cm (sd) 71 (26) 77 (11) 99 (14)* 80 (13) 100 (15)*
Total cholesterol, mg/dL^ (sd) 214 (50) 220 (52) 205 (47) 218 (52) 205 (47)
% High, ≥200 mg/dL (n) 58 (62) 59 (36) 57 (26) 58 (42) 57 (20)
LDL cholesterol, mg/dL^ (sd) 137 (50) 145 (50) 127 (49)* 143 (50.0) 126 (48)
% High, ≥ 130 mg/dL (n) 46.7 (50) 47.5 (29) 45.7 (29) 50.0 (36) 40.0 (14)
HDL cholesterol, mg/dL^ (sd) 53 (14) 57 (12) 48 (15)* 54 (13) 50 (17)
% Low, < 50 mg/dL (n) 19 (18) 7 (4) 33 (15)* 13 (9) 29 (10)*
Triglycerides, mg/dL^ (sd) 118 (75) 93 (57) 152 (83)* 105 (69) 147 (80)*
% High, ≥ 130 mg/dL (n) 34 (36) 16 (10) 57 (26)* 26 (19) 49 (17)*
VLDL cholesterol, mg/dL^ (sd) 24 (15) 19 (11) 30 (17) 21 (14) 29 (17)
Lp(a)^, mmol/L (sd) 39 (43) 39 (43) 39 (43) 40 (45) 37 (39)
hs-CRP, mg/L^ (sd) 0.1 (0.2) 0.1 (0.1) 0.2 (0.2)* 0.1 (0.2) 0.2 (0.2)*
ICAM-1, ng/L^ (sd) 295 (86) 282 (95) 312 (71)* 278 (90) 331 (65)*
P-selectin, ng/L^ (sd) 136 (46) 129 (46) 145 (46) 131 (46) 146 (46)
TNF alpha, pg/L^ (sd) 2140 (590) 2041 (501) 2271 (675) 2001 (499) 2425 (665)*
SBP, mmHg (sd) 112 (11) 111 (10) 114 (13) 112 (11) 113 (13)
% SBP > 95th percentile (n) 14 (15) 12 (7) 17 (8) 13 (9) 17 (6)
DBP, mmHg (sd) 63 (7) 62 (8) 64 (6) 63 (8) 63 (6)
% DBP > 95th percentile (n) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Caption: All continuous variables are presented as mean (standard deviation [sd]). All categorical variables and percentiles are presented as % (n). ^variables were
log-transformed prior to testing for differences. *p value for comparisons < 0.05. Other racial groups were defined as Asian, Hispanic, Pacific Islander, and
Native American.
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other risk markers, inflammatory factors may be modifi-
able through weight loss via a prudent diet and physical
activity [24]. Furthermore, the American College of Cardi-
ology, the American Heart Association and the Canadian
Cardiovascular Society recommend measuring inflamma-
tion by high-sensitivity C-reactive protein (hs-CRP) to
identify patients who could obtain particular benefit from
statin therapy [5,25].
As with adults, children are routinely assessed using
anthropometric measures. This is done to identify individ-
uals with abnormal growth due to malnutrition, endocrinedisorders, or those at risk for premature cardiovascular
disease and mortality [3]. Childhood overweight and obes-
ity, defined respectively by the Centers for Disease Control
as a BMI ≥ the 85th and 95th percentile for age and sex
[14], is a growing problem around the world. In developed
countries, the prevalence of overweight and obesity ranges
from 5% in Turkey to 33% in the United States [26].
Childhood adiposity also tends to track throughout the
life-course, increasing the risk that obese children will be-
come obese adults [27]. While assessment of overall adi-
posity using BMI percentile is a well-accepted approach in
cardiovascular risk assessment in children, measurement















HDL −0.74 0.02 −0.07 −0.06
LDL −0.11 0.04 −0.19 0.43
Triglycerides 0.93 0.02 0.11 −0.18
VLDL 0.93 0.00 0.08 −0.17
Lp(a) 0.10 0.01 0.01 0.75
hs-CRP 0.37 0.33 0.47 0.11
ICAM 0.01 0.86 −0.19 −0.04
P-selectin 0.23 0.18 −0.18 −0.51
TNF −0.02 0.84 0.21 −0.04
Systolic BP 0.06 −0.01 0.66 −0.50
Diastolic BP 0.08 −0.04 0.78 0.03
% variance
explained
25% 14% 12% 10%
Caption: Correlations greater than 0.6 are indicated in bold.
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lished practice. One impediment has been the lack of
age, sex and ethnic specific percentiles for measures
of abdominal adiposity. Only recently have these become
available through large representative cross-sectional sur-
veys [21,28].
We compared the associations of BMI and WC per-
centile with risk marker patterns in a population of chil-
dren referred to a pediatric cardiology clinic. In addition
to more standard CVD risk factors, we also measured
four inflammatory markers (TNF-αR2, P-selectin, ICAM-1,
and hs-CRP) that have been associated either with excess
adiposity and atherosclerosis in animal and autopsy studies,
pre-clinical vascular testing and as predictors of adult
cardiovascular disease events [18]. We used PCA to iden-
tify major patterns of risk markers, greatly reducing theTable 3 Association of BMI and WC percentiles with quintiles
Lipid pattern Inflammatory pa
Beta P for
trend
pR2 Beta P fo
tren
BMI % 0.12 (0.03) <0.01 20% 0.01 (0.03) 0.72
WC % 0.11 (0.03) < 0.01 22% 0.05 (0.03) 0.09
BMI % adjusted
for WC %
0.89 (0.06) 0.14 2% −0.14 (0.07) 0.03
WC % adjusted
for BMI %





by using both metrics
None
Caption: Beta coefficients are evaluated as change in quintile rank corresponding to
parentheses. All models are adjusted for exposure to cigarette smoke, family history
other race. pR2 – partial R2, representing the independent explanatory power of eacnumber of individual statistical tests required, and simpli-
fying the interpretation of results.
The first four patterns of risk markers roughly corre-
sponded to an abnormal lipid pattern, an abnormal in-
flammatory marker pattern, an abnormal blood pressure
pattern and an abnormal Lp(a) pattern. The lipid pattern
accounted for the most variance in risk markers, and
was consistent with a pattern reflecting obesity related
dyslipidemia. The inflammatory pattern was character-
ized by increased levels of all markers except hs-CRP.
We are unclear why abnormal hs-CRP levels were not
associated with this pattern, however it could be due to
the low level of variation in hs-CRP in this relatively
young population. We found that BMI and WC percen-
tiles were similarly associated with the lipid pattern,
which is consistent with others findings in adults sug-
gesting that both abdominal and general adiposity are
associated with abnormal lipids. Neither BMI nor WC
percentile was significantly associated with inflamma-
tory, BP, or Lp(a) patterns. A different scenario emerged
when both measures were used simultaneously. When
BMI and WC percentiles were included in the same
model, neither was significantly associated with the lipid
pattern – indicating that using WC percentile in addition
to BMI percentile adds no significant advantage in pre-
dicting lipid abnormalities than using either alone. How-
ever WC and BMI percentile were significantly associated
with the inflammatory pattern, but in opposite directions.
In this model, BMI percentile adjusted for WC percentile
can be interpreted as anti-or non-inflammatory lean mass;
whereas WC percentile adjusted for BMI percentile is
interpreted as pro-inflammatory abdominal adipose tissue.
The separation and independent consideration of these
measures greatly improves the prediction of abnormal
levels of inflammatory factors.
Our study supports the simultaneous use of both BMI
and WC percentiles in cardiovascular risk assessment inof factor scores
ttern BP pattern Lp(a) pattern
r
d
pR2 Beta P for
trend
pR2 Beta P for trend pR2
5% 0.07 (0.03) 0.14 8% 0.00 (0.03) 0.98 8%
8% 0.06 (0.03) 0.06 7% 0.01 (0.03) 0.84 8%
5% 0.09 (0.07) 0.21 2% −0.02 (0.07) 0.76 0%
8% −0.01 (0.06) 0.84 0% 0.02 (0.06) 0.71 0%
12% 2% 0%
4-7% None None
a 5% increase in BMI or WC percentiles. Standard errors are presented in
of cardiovascular disease, hours of screen-time, white race, black race and
h predictor.
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creasingly recommended for adults, and we anticipate
this to be the case for children in the future. WC is easy
to obtain and as a percentile was at least as good as BMI
in predicting lipid abnormalities in our study. Used in
conjunction with BMI percentile, WC percentile pro-
vides clearer information on underlying cardiovascular
risk due to inflammation. However, the clinical utility
of using WC percentile in addition to BMI percentile
needs to be further assessed in prospective studies
using hard endpoints (e.g. incident type 2 diabetes,
cardiovascular disease) that occur after the initial risk
assessment.
Our study has several strengths. First, it reports levels
of inflammatory markers in a group of children at high-
risk for future early CVD. Inflammatory markers are not
routinely measured in children, and there is little data in
the literature on what is ‘normal’ [29]. However, it is
relatively clear that inflammation is a key component of
cardiovascular risk in adults, and is likely to be in chil-
dren as well. Second, we used PCA to identify major risk
marker patterns rather than performing individual ana-
lyses on each one. This substantially reduced the num-
ber of statistical tests we had to perform, and simplified
the interpretation of the results. Third, our study is one
of the first to contrast the predictive power of BMI vs
WC percentiles on risk markers in children.
Our study has some limitations. First, the cross-
sectional design of our study means that temporal rela-
tionships cannot be definitively established. However
there is strong evidence that adipose tissue is a causal
factor in the appearance of cardiovascular risk factors.
Second, we did not measure dietary intake or physical
activity, which means that associations between adiposity
and risk marker patterns may be overestimated. Third,
waist circumference percentiles were derived from aggre-
gate percentile data that was rounded – which could lead
to error in estimates. Fourth, we studied a small number
of mostly non-hispanic whites, which limited both our
statistical power and generalizability.
Conclusions
In a sample of children at high-risk for developing car-
diovascular disease, BMI percentile and WC percentile
explained similar variance in a pattern of abnormal
lipids, however WC percentile used in conjunction with
BMI percentile explained the most variance in a pattern
of elevated inflammatory factors. This suggests that both
WC percentile and BMI percentile should be used for
risk assessments of high-risk children.
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